Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $144.9 million.

  • Immunocore Holdings' Accumulated Expenses fell 2651.15% to $144.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.9 million, marking a year-over-year decrease of 2651.15%. This contributed to the annual value of $185.5 million for FY2024, which is 5482.46% up from last year.
  • Immunocore Holdings' Accumulated Expenses amounted to $144.9 million in Q3 2025, which was down 2651.15% from $143.8 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Accumulated Expenses ranged from a high of $197.2 million in Q3 2024 and a low of $76.7 million during Q4 2022
  • For the 4-year period, Immunocore Holdings' Accumulated Expenses averaged around $143.2 million, with its median value being $143.8 million (2025).
  • Per our database at Business Quant, Immunocore Holdings' Accumulated Expenses soared by 5614.29% in 2023 and then plummeted by 2651.15% in 2025.
  • Immunocore Holdings' Accumulated Expenses (Quarter) stood at $76.7 million in 2022, then surged by 56.14% to $119.8 million in 2023, then soared by 54.82% to $185.5 million in 2024, then fell by 21.88% to $144.9 million in 2025.
  • Its Accumulated Expenses was $144.9 million in Q3 2025, compared to $143.8 million in Q2 2025 and $118.3 million in Q1 2025.